Stocks · Health care · Pharmaceutical Preparations

Dermata Therapeutics, Inc.

DRMA Clue Score42
United States Fiscal year ends December CIK 0001853816 Results filed 11 Aug 2026

What the insiders did Net buying

By person

6 insiders · 2 transactions
1.2×

Gerald T. Proehl holds only 1.2 times base salary in stock. $348.26K of shares against $280.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Gerald T. Proehl last reported holding, valued at $1.19, the price Common Stock was last bought or sold at on the open market here, on 16 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Munera Maria E Bedoya-Toro
SVP, Regulatory Affairs
$1.27K (1)
—
+$1.27K
1,012
$1.20K
+8,333%
Kathleen D. Scott
Director
—
$13.09 (1)
−$13.09
0
$0.00
−100.0%
Gerald T Proehl
President, Chairman, CEO
—
—
—
292,631
$348.26K
—
Hoose Kyri K. Van
SVP, CFO
—
—
—
232,463
$276.65K
—
Mary Fisher
Director
—
—
—
196,946
$234.39K
+207,212%
David F Hale
Director
—
—
—
80,957
$96.35K
+3,553%

No percentages here. This company's share count has moved by a factor of 8.0 over the window, from 681,557 to 5,430,648 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.